Modulation of resistance to ara-C by bryostatin in fresh blast cells from patients with AML

This publication has 21 references indexed in Scilit:

• 10 Multidrug resistance in acute myeloid leukaemia
  Bailliere's Clinical Haematology, 1996
• Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-d-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells
  Biochemical Pharmacology, 1994
• A phase I study of intravenous bryostatin 1 in patients with advanced cancer
  British Journal of Cancer, 1993
• Towards selective pharmacological modulation of protein kinase C – opportunities for the development of novel antineoplastic agents
  British Journal of Cancer, 1992
• In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-β-d-arabinofuranosylcytosine in human leukemia cells
  Biochemical Pharmacology, 1991
• Complexities of the Protein Kinase C Pathway
  Molecular Carcinogenesis, 1991
• The Cell membrane and cell signals: New targets for novel anticancer drugs
  Annals of Oncology, 1990
• Effect of cell growth and cell differentiation on 1‐β‐d‐arabinofuranosylcytosine metabolism in myeloid cells
  British Journal of Haematology, 1989
• The mechanism of protein kinase C activation
  Trends in Neurosciences, 1989
• The action of arabinosylcytosine on synchronously growing populations of mammalian cells
  Biochemical and Biophysical Research Communications, 1968